Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #41,201 to #41,250.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. "sandbox:S.I.a" (2 revisions)
  2. "template:Mandana.S" (2 revisions)
  3. "template:Mandana.Sa (2 revisions)
  4. "template:N.H" (2 revisions)
  5. ''Asparagaceae'' (2 revisions)
  6. (-)-2β-Carbomethoxy-3β-(4-iodophenyl)tropane (2 revisions)
  7. (Bis(trifluoroacetoxy)iodo)benzene (2 revisions)
  8. (Fibrous Connective Tissue) (2 revisions)
  9. -35 sequence gene transcriptions (2 revisions)
  10. -itis (2 revisions)
  11. -mania (2 revisions)
  12. 1,4,6-Androstatrien-3,17-dione (2 revisions)
  13. 1,4,6- androstatrien-3,17-dione (2 revisions)
  14. 1,4,6-androstatrien-3,17-dione (2 revisions)
  15. 11-nor-9-Carboxy-THC (2 revisions)
  16. 11β-Hydroxysteroid dehydrogenase type 1 (2 revisions)
  17. 14-Ethoxymetopon (2 revisions)
  18. 14-Methoxymetopon (2 revisions)
  19. 14-Phenylpropoxymetopon (2 revisions)
  20. 17-N-Allylamino-17-demethoxygeldanamycin (2 revisions)
  21. 17-beta-hydroxysteroid dehydrogenase 3 deficiency overview (2 revisions)
  22. 17-beta-hydroxysteroid dehydrogenase deficiency case study one (2 revisions)
  23. 17-beta-hydroxysteroid dehydrogenase deficiency cost-effectiveness of therapy (2 revisions)
  24. 17-beta-hydroxysteroid dehydrogenase deficiency future or investigational therapies (2 revisions)
  25. 17 alpha-hydroxylase deficiency classification (2 revisions)
  26. 18-Hydroxylase deficiency (2 revisions)
  27. 19-Norandrosterone (2 revisions)
  28. 2',3'-Cyclic-nucleotide 3'-phosphodiesterase (2 revisions)
  29. 2,4-Dinitrotoluene (2 revisions)
  30. 2,5-Dimethoxy-4-bromoamphetamine (2 revisions)
  31. 2,Alpha-DMT (2 revisions)
  32. 2,N,N-TMT (2 revisions)
  33. 2-Aminopurine (2 revisions)
  34. 2-Arachidonyl glyceryl ether (2 revisions)
  35. 2-Bromo-4,5-methylenedioxyamphetamine (2 revisions)
  36. 2-Hydroxyglutaric aciduria (2 revisions)
  37. 2-Oxazolidone (2 revisions)
  38. 2-methylbutyryl-coenzyme a dehydrogenase deficiency (2 revisions)
  39. 20-hydroxyecdysone (2 revisions)
  40. 2005–present Chikungunya outbreak (2 revisions)
  41. 2006 North American E. coli outbreak (2 revisions)
  42. 2017 ACG guidelines for the indications to test for and to treat Helicobacter pylori infection (2 revisions)
  43. 21-Hydroxylase Deficiency CT (2 revisions)
  44. 21-Hydroxylase Deficiency case study one (2 revisions)
  45. 21-Hydroxylase Deficiency cost-effectiveness of therapy (2 revisions)
  46. 21-Hydroxylase Deficiency differential diagnosis (2 revisions)
  47. 21-Hydroxylase Deficiency future or investigational therapies (2 revisions)
  48. 21-Hydroxylase Deficiency genotyping (2 revisions)
  49. 21-Hydroxylase Deficiency historical perspective (2 revisions)
  50. 21-Hydroxylase Deficiency laboratory findings (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"